Spikevax bivalent Original / Omicron 0.1 mg/mL dispersion for injection
Spikevax bivalent Original / Omicron is indicated for active immunisation to prevent COVID 19 disease caused by SARS- CoV-2 in individuals 18 years of age and older.
Patient Information Leaflet
Summary of Product Characteristics
Spikevax (previously COVID-19 Vaccine Moderna)
Spikevax 0.2 mg/ml formulation
Interim authorisation is granted for the Spikevax emergency therapeutic product by the Health Sciences Authority (HSA) of Singapore for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 years of age and older.
The use of this vaccine should be in accordance with official recommendations.
Patient Information Leaflet
Summary of Product Characteristics
Spikevax (previously COVID-19 Vaccine Moderna)
Spikevax 0.1 mg/ml formulation
Interim authorisation is granted for the Spikevax emergency therapeutic product by the Health Sciences Authority (HSA) of Singapore for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 months of age and older.
The use of this vaccine should be in accordance with official recommendations.
Patient Information Leaflet
Summary of Product Characteristics
Tools
Temperature Excursion Tool
See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.
Report Adverse Events
You can report any adverse events to Moderna via the Adverse Event Intake Portal or by calling 1-800-622-4937.
Contact Moderna
8am-5pm SST – Mon - Fri
APACmedinfo@modernatx.com